Motion sickness is a motion-induced syndrome that manifests with some or all of the
following signs and symptoms: malaise, flushing or pallor, diaphoresis, headache, gastric
hypomotility associated with abdominal awareness, abdominal discomfort and/or vomiting,
cardiovascular changes, and endocrine changes. Motion sickness occurs on ships,
submarines, aircraft, in automobiles, trains, amusement park rides, simulators, in
spacecraft, and with the use of virtual reality devices. The spectrum of severity of
symptoms ranges from mild discomfort to severe compromise of function to prostration from
continual emesis leading to dehydration. Incapacitation of key personnel can be
Several theories of the etiology of motion sickness are described in the medical
literature. Most of these theories are variations of a theme that asserts that the
symptoms of motion sickness arise when the brain is unable to resolve a conflict between
the various sensory modalities that provide information regarding position and movement of
the body. These modalities include tilt/linear acceleration and angular acceleration from
the otolith organs and the semicircular canals, respectively, visual information, and
proprioception. A commonly cited example is reading a book while riding in an automobile.
The vehicle occupants visual reference (the book) is not moving (or is moving
minimally) relative to the occupant and therefore the occupant perceives him/herself as
stable in space based on visual input. However, vestibular input, in a predictable
response to bumpy roads, cornering and hills, is that of variable movement. A naïve
Sailor below deck on a ship in rolling seas without visual reference to the horizon
experiences a similar phenomenon. Without visual reference to the horizon, the motion of
the ship is perceived by the vestibular and proprioceptive systems while the bulkheads do
not appear to move relative to the observer. This mismatch of sensory information somehow
gives rise to the release of a neurochemical agent (neurotransmitter) that acts in the
general region of the Area Postrema, stimulating the nearby vomiting center.
One theory postulates that the sensory conflict described above stimulates a response
in the brain stem similar to that caused by some neurotoxins. Proponents of this theory
describe the signs and symptoms of motion sickness as the result of the stimulation, by
motion, of a "poison-response mechanism." This mechanism evolved to rid the body
of toxic ingested substances by emptying the stomach, and countering or minimizing the
effects of absorbed toxin via a stress response of the sympathetic nervous system.
Of particular interest is the fact that a functional vestibular system is required for
an individual to suffer from motion sickness. In individuals and animals in whom the
vestibular apparatus has been ablated or the vestibular pathway interrupted, motion
sickness has not been induced, despite extensive effort. Supporting the
"poison-response" theory is the fact that toxin-induced emesis can be reduced in
dogs by labyrinthectomy.
Diagnosis of motion sickness is straightforward. However, a differential diagnosis
should be considered in cases of persistent illness or illness refractory to management.
Most individuals adapt to a motion environment over a period of time that varies in
length. Personnel should be advised to minimize their exposure to motion by residing
amidships or over the wing in airplanes, and to limit their own head movements to prevent
confusing vestibular input. Additionally, maintaining a visual reference to the horizon
should be helpful. Alcohol intake in the previous 24 hours has been shown to reduce
tolerance to cross-coupled stimulation during desensitization training. Thus, limiting
alcohol intake may reduce susceptibility.
Pharmacological intervention can be prophylactic or therapeutic. Medications
antihistamines, often used in combination with
When administering a drug for prophylaxis, the timing of administration relative to
exposure is particularly important. Prophylactic drugs should be given before nausea and
vomiting occur. Susceptible individuals should be given meclizine 25 mg orally or
diphenhydramine 25 to 50 mg orally, one hour before departure.
In the aviation community, motion sickness is seldom seen in experienced
aviators and aircrew. During training, Student Naval Aviators (SNAs) who are experiencing
problems with motion sickness severe enough to compromise their performance, undergo a
history and physical exam by a flight surgeon to rule out organic disease. If no
identifiable pathology is detected, a combination of promethazine
(Phenergan) 25mg and
ephedrine 25mg PO is given one hour before flight, for up to three flights. The student
must be accompanied with an instructor pilot, after ruling out other illness. If the
problem persists, the SNA is referred to the Naval Operational Medicine Institute (NOMI)
for desensitization, biofeedback, and relaxation training and psychological counseling.
The Aeromedical Reference and Waiver Guide cites a success rate of 85 percent of referred
Interestingly, 70 percent of Shuttle astronauts suffer from Space Motion Sickness (SMS)
to some degree. SMS differs from "terrestrial" motion sickness in that
typically, there is no diaphoresis, flushing is more common than pallor, and vomiting
frequently occurs without nausea or other warning. NASA formerly used a combination
therapy consisting of scopolamine 0.4mg and
dexedrine 5.0 mg PO as prophylaxis taken
before launch. Current NASA policy is to use promethazine
(Phenergan) 50mg IM
therapeutically when SMS becomes a problem. Unless symptoms are severe, the astronauts are
usually instructed to take it before sleep to take advantage of the medications
depressant effect and minimize its effect on mission tasks.
In one study comparing the efficacy of four medications in reversing severe nausea
(diphenhydramine 50mg IM, promethazine 25mg IM,
promethazine 50mg IM and scopalamine 0.5mg
IM) the scopalamine 0.5mg and promethazine
50mg doses were effective. Little or no benefit
was seen with the others. It is felt that IM promethazine
is preferred to IM scopalamine in these doses due to the potential toxic effects of the latter drug.
Since these medications act as central depressants they can affect performance and
impact safety. Over the counter medications include Dramamine and Bonine.
Contraindications in the use of cholinergics should be observed. Other drugs that are used
to treat nausea and vomiting that arise from other causes have been ineffective in
treating motion sickness. These include metoclopramide,
prochloroperazine, and odansetron.
Ginger products are widely touted as providing prophylaxis for or relief from the
nausea and vomiting of motion sickness. Studies
Triesman M. Motion sickness: an evolutionary hypothesis. Science, 197:493-5, 1977.
2 Money KE and Cheung BS. Another function of the inner ear: facilitation of the
emetic response to poisons. Aviat Space Environ Med. 54:208-11, 1983.
3 Bagshaw M and Stott JRR. The desensitization of chronically motion sick aircrew
in the Royal Air Force. Aviat Space Environ Med 56:1144-51, 1985.
4 Stott JR. Management of acute and chronic motion sickness. AGARD Lecture Series
175, 11-1, 1991.
5 Graybiel A and Lackner JR. Treatment of severe motion sickness with anti-motion
sickness drug injections. Aviat Space Environ Med 58:773-6, 1987.
6 Stott JR. Management of acute and chronic motion sickness. AGARD Lecture Series
175, 11-1, 1991.
Submitted by LCDR Edwin Y. Park, MC, USNR, Naval Operational Medicine Institute,
Pensacola, FL (1999).
Approved for public release; Distribution is unlimited.